Development of a prognostic score for wheelchair seating changes
Official title: Wheelchair Seating Users With Neuromuscular Diseases: Elaboration of a Pronostic Score of Changes on the Seating System of the Wheelchair
Run by Assistance Publique - Hôpitaux de Paris · NCT05785546 · Data updated 2026-11-12
This study is trying to create a scoring system to help determine when people with neuromuscular diseases need changes in their wheelchair seating to stay healthy and improve their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 368 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Garches) |
| Status | Recruiting |
| Started | February 19, 2025 |
| Main results expected | February 2028 |
| Study ends | March 2028 |
| Registry record updated | March 19, 2025 |
| Trial ID | NCT05785546 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 who are daily wheelchair users with neuromuscular diseases like Duchenne Muscular Dystrophy or Infantile Spinal Muscular Atrophy type II.
✕Probably not a fit
Patients who have recently undergone surgery, have a current seat change prescription, or are pregnant or breastfeeding may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on developing and validating a prognostic score to assess the need for changes in wheelchair seating systems for individuals with neuromuscular diseases. It involves a prospective longitudinal multicenter cohort across eight centers, with four centers dedicated to developing the score and four for validation. The aim is to analyze seated postural installation in wheelchairs to prevent health complications and improve the quality of life for users. Occupational therapists and doctors of Physical Medicine and Rehabilitation will conduct assessments to inform necessary interventions.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life for wheelchair users by providing tailored recommendations for seating adjustments that prevent complications.
How similar studies have gone: While there is limited literature in this specific area, the approach of developing prognostic scores for wheelchair users is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female over the age of 18 * Daily wheelchair user (more than 4 hours per day) * Having a neuromuscular disease such as Duchenne Muscular Dystrophy or Infantile Spinal Muscular Atrophy type II * Accompanied by an identified medical equipment provider, able to respond to the recommendations of the clinical team * Patient informed and having signed consent. Exclusion Criteria: * Person who already has a seat change or FR prescription at the time of inclusion * Having undergone surgery less than 1 year ago or a fracture * Pregnant or breastfeeding women * Patient under guardianship or curatorship.
Where it's running
-
New technology Platform department, Raymond Poincaré Hospital, APHP
Garches, France Recruiting
Study contacts
- Principal investigator: Samuel Pouplin, PhD — New technology Platform department, Raymond Poincaré Hospital, APHP
- Study coordinator: Samuel Pouplin, PhD
- Email: samuel.pouplin@aphp.fr
- Phone: + 33 (0)1.47.10.70.61
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Wearable monitoring of walking and arm movement in adults with neuromuscular or metabolic movement disorders
This project uses a wrist/ankle wearable to continuously monitor walking and upper-limb movement in ambulant adults with neuromuscular diseases or obesity to see if digital measures like stride speed track real-life motor function.
-
Precision diagnosis and therapy for rare eye and neuromuscular diseases
This study is testing new ways to find the genetic causes of rare eye and muscle diseases to help create more personalized treatments for patients.
-
Research network for hereditary spastic paraplegia and primary lateral sclerosis
This study is trying to learn more about hereditary spastic paraplegia and primary lateral sclerosis by enrolling people with specific types of the condition to help find better treatments and understand how these diseases progress.
-
Study of limb movements in patients with neuromuscular diseases
This study is testing new technology to see how well it can track and understand limb movements in people with neuromuscular diseases compared to those without any movement issues.
-
Using MSOT to Diagnose and Monitor Neuromuscular Diseases in Children
This study is testing a new type of scan to see if it can help doctors diagnose and track the progress of neuromuscular diseases in children without needing invasive procedures.
-
Evaluating a new breathing device for patients with neuromuscular diseases
This study is testing a new breathing device that adjusts to patients' needs to see if it helps people with neuromuscular diseases breathe better than their current equipment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.